New York City, NY -- (SBWIRE) -- 12/18/2013 -- StockMarketIntel.com issues a special report on the following stocks: Vapor Corp., (OTCMKTS:VPCO), Bayer AG (ADR) (OTCMKTS:BAYRY), Cellceutix Corp (OTCMKTS:CTIX), TENCENT HOLDINGS ADR (OTCMKTS:TCEHY)
Vapor Corp., (OTCMKTS:VPCO) declined -2.33%, trading on 541,770 shares, to end the trade at $1.68. If we look at its trading history of the past 52 weeks, the share price suffered a low of $0.20 and was moved to the maximum level of $2.00. The stock changed hands in a range of $1.56 to $1.76, bringing its market capitalization to about $101.43 million. Vapor Corp. designs, markets, and distributes electronic cigarettes and accessories primarily in the United States and Canada. The company?s electronic cigarettes are battery-powered products that enable users to inhale nicotine vapor without smoke, tar, ash, or carbon monoxide.
Has VPCO Found The Bottom and Ready To Move Up? Find Out Here
Bayer AG (ADR) (OTCMKTS:BAYRY) declined -0.14%, to complete the trading session at $133.14, with a total volume of 17,767 shares. The stock, on average, trades on a volume of 29,935 shares. In the past 52 weeks, the share price has not declined below $91.85 and above $134.03. It floated in a range of $132.35 to $133.22 during the last trading session, with a beta value of 1.23. Its market capitalization now moved to about $110.10 billion. Bayer Aktiengesellschaft develops, produces, and markets health care and agriculture products, and high-tech materials worldwide. The company?s HealthCare segment provides pharmaceuticals, such as prescription pharmaceuticals for the treatment of hypertension, cardiovascular and infectious diseases, cancer, multiple sclerosis, and contraception.
Has BAYRY Found The Bottom And Ready To Gain Momentum? Find Out Here
Cellceutix Corp (OTCMKTS:CTIX) recorded a gain of 3.78% and was in a range of $1.85-$1.92 before closing at $1.92. The share price hit its 52-week low of $1.40 and $2.47 was the best price. The stock completed the day with a total volume of 96,055 shares, versus an average volume of 188,967 shares. Cellceutix Corporation, a development stage biopharmaceutical company, engages in the discovery and development of small molecule drugs to treat diseases primarily in the areas of cancer and inflammatory disease.
What was the Moving Force behind CTIX on Bullish Run? Read This Research Report
TENCENT HOLDINGS ADR (OTCMKTS:TCEHY) declined -2.39% yesterday, bringing its market capitalization around $114.61 billion. The total number of shares that changed hands during the session was 47,226shares, as compared to average trading volume of 60,834 shares. The share price, after opening at $60.33, made a high of $60.33 and hovered above $59.92 to end the day at $60.15.
Why Should Investors Buy TCEHY After the Recent Fall? Just Go Here and Find Out
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list.
Neither StockMarketIntel.com, nor its employees and affiliates are registered as investment advisors or broker/dealers in any jurisdiction whatsoever. Through use of this website viewing or using you agree to hold StockMarketIntel.com, its operators, owners, employees, and affiliates harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Readers should always do their own due diligence and consult a financial professional. StockMarketIntel.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and StockMarketIntel.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled company. Any opinions expressed on this website are statements of judgment as of the date of publication and are subject to change without further notice, and may not necessarily be reprinted in future publications or elsewhere.
Read Full disclaimer at: http://stockmarketintel.com/Disclaimer.htm
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)